SPAREBANKEN ØST And 2 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – SPAREBANKEN ØST (SPOG.OL), EQUASENS (EQS.PA), MOWI (MOWI.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. SPAREBANKEN ØST (SPOG.OL)

35.8% sales growth and 6.25% return on equity

Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; mortgages on homes; and debenture financing for second-hand cars, as well as services in the areas of financing, savings and investment, and money-transfer. It also distributes insurance, fund shares, interest rate hedging, and currency, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.

Earnings Per Share

As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr6.62.

PE Ratio

SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 6.71. Meaning, the purchaser of the share is investing kr6.71 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.25%.

Volume

Today’s last reported volume for SPAREBANKEN ØST is 2504 which is 87.38% below its average volume of 19852.

Moving Average

SPAREBANKEN ØST’s value is below its 50-day moving average of kr48.85 and under its 200-day moving average of kr48.62.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 691.4M for the twelve trailing months.

Yearly Top and Bottom Value

SPAREBANKEN ØST’s stock is valued at kr44.40 at 22:20 EST, way below its 52-week high of kr59.20 and higher than its 52-week low of kr43.10.

More news about SPAREBANKEN ØST.

2. EQUASENS (EQS.PA)

11.3% sales growth and 28.59% return on equity

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.

Sales Growth

EQUASENS’s sales growth is 11.3% for the ongoing quarter and 11.3% for the next.

Moving Average

EQUASENS’s worth is under its 50-day moving average of €77.40 and under its 200-day moving average of €76.13.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 30, 2022, the estimated forward annual dividend rate is 1.05 and the estimated forward annual dividend yield is 1.34%.

More news about EQUASENS.

3. MOWI (MOWI.OL)

9.3% sales growth and 23.04% return on equity

Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, MOWI has a trailing twelve months EPS of kr2.27.

PE Ratio

MOWI has a trailing twelve months price to earnings ratio of 83.16. Meaning, the purchaser of the share is investing kr83.16 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.04%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 20.9% and a drop 1.7% for the next.

More news about MOWI.

Leave a Reply

Your email address will not be published. Required fields are marked *